Application
Antibodies tested include p-EGFR (Tyr 1173): (A, B, C) and EGFR (1005): (D, E, F).Application
Western blot analysis of EGFR phosphorylation in untreated (A), EGF treated (B) and EGF and lambda protein phosphatase treated (C) A-431 whole cell lysates.Application
Western blot analysis of EGFR phosphorylation in untreated (A) and lambda protein phosphatase treated (B) A-431 whole cell lysates.Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing membrane staining.Application
Western blot analysis of phosphorylated EGFR expression in untreated (A) and EGF-treated (B) A-431 whole cell lysates.| Product Name | p-EGFR Antibody (Tyr 1173) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | epitope corresponding to phosphorylated Tyr 1173 of EGFR of human origin |
| Modification | Phosphoralated |
| Modification Notes | Epidermal growth factor mediates its effects on cell growth through its inter-action with a cell surface glycoprotein designated the EGF receptor. Binding of EGF or TGF alpha to the EGF receptor activates tyrosine-specific protein kinase activity intrinsic to the EGF receptor. The carboxy terminal tyrosine residues on EGFR, Tyr 1068 and Tyr 1173, are the major sites of autophosphorylation, which occurs as a result of EGF binding. Once activated, EGFR mediates the binding of the phosphotyrosine binding (PTB) domain of GRB2 through direct interactions with Tyr 1068 and Tyr 1086 and through indirect interactions with Tyr 1173 in the Ras signaling pathway. Tyr 1173 of EGFR also functions as a kinase substrate. Phosphorylation of Tyr 992, Tyr 1068 and Tyr 1086 is required for conformational change in the C-terminal tail of the EGF receptor. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIPIFIHC |
| recommended for detection of Tyr 1173 phosphorylated EGFR of human and mouse origin and correspondingly phosphorylated Tyr 1172 of rat origin by WB, IP, IF and IHC(P): |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Alternative Names | epitope corresponding to phosphorylated Tyr 1173 of EGFR of human origin |
|---|---|
| Tissue Specificity | epitope corresponding to phosphorylated Tyr 1173 of EGFR of human origin |
| Entrez Gene | 1956 |
|---|
Application
Antibodies tested include p-EGFR (Tyr 1173): (A, B, C) and EGFR (1005): (D, E, F).
Application
Western blot analysis of EGFR phosphorylation in untreated (A), EGF treated (B) and EGF and lambda protein phosphatase treated (C) A-431 whole cell lysates.
Application
Western blot analysis of EGFR phosphorylation in untreated (A) and lambda protein phosphatase treated (B) A-431 whole cell lysates.
Application
Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing membrane staining.
Application
Western blot analysis of phosphorylated EGFR expression in untreated (A) and EGF-treated (B) A-431 whole cell lysates.| Application Notes | recommended for detection of Tyr 1173 phosphorylated EGFR of human and mouse origin and correspondingly phosphorylated Tyr 1172 of rat origin by WB, IP, IF and IHC(P): |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
